COntralateral CorticoSTeroid Injection in Total Knee Arthroplasty

Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorUnity Health Toronto

About this trial

Through a triple-blinded randomized control trial, the primary purpose of this pilot study is to assess the efficacy of administering peri-operative contralateral corticosteroid injection in patients undergoing TKA. The secondary outcome was to assess the effect of contralateral corticosteroid injection on pain and functional outcomes of patients undergoing TKA.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients 18 years of age and older

Primary osteoarthritis diagnosis with indication for primary elective unilateral TKA

No previous contralateral knee injections (steroids/biologics) within one year of study

Not scheduled for bilateral TKA or a subsequent staged contralateral TKA within the next six months

Disqualifiers

Other aetiologies of OA that warrants TKA (inflammatory or post traumatic arthritis)

Cognitive impairment (dementia, Alzheimer's, uncontrolled delirium) which will prevent patients from completing primary outcome measure or comply with follow-up requirements

Previous TKA or ORIF or nailing on either knee

Previous or active knee infection or extensor mechanism disruption

Trial design

Design model

Parallel

Treatments tested in this trial

  • Corticosteroid Injection - 80mg methylprednisolone (total volume 2ml) with 6 mL of 1% Bupivacaine without epinephrine (Total Volume 8 mL).

    Drug

    Corticosteroid Injection - 80mg methylprednisolone (total volume 2ml) with 6 mL of 1% Bupivacaine without epinephrine (Total Volume 8 mL).

  • Band-Aid

    Other intervention

    Band-Aid

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Group A - Corticosteroid InjectionExperimental treatment 1 intervention
Group B: Group B - Band-Aid PlacementSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Oxford Knee Score (OKS)

Repeated mean score of a short questionnaire consisting of 12 questions ranging from 0 to 48 points, designed to assess function and pain after knee replacement surgery. Higher values represent a better outcome.

Time frame
4-, 8-, 12-weeks and 1-year post-surgery

Secondary outcomes

1

Visual Analogue Scale (VAS) Pain Score

Assess pain from a visual scale that ranges from 0 to 10. Straight line with the endpoints defining extreme limits such as 'no pain at all' (zero) and 'pain as bad as it could be' (ten). Assess both the operative and injected knees.

Time frame
4-, 8-, 12-weeks and 1-year post-surgery
2

EuroQol five-dimensional descriptive system (EQ-5D-5L)

The European Quality of Life 5 Dimensions (EQ5D) is a patient reported outcome where patients self rate their level of severity of health status and health related quality of life. Consists of 5 dimensions (mobility, selfcare, usual activities, pain/discomfort, anxiety/depression) and each one of them has 5 levels (no problems, slight problems, moderate problems, severe problems, and extreme problems) where patients will indicate how they feel regarding their health status and quality of life.

Time frame
4-, 8-, 12-weeks and 1-year post-surgery
3

Knee range of motion (ROM)

The therapist/assessor uses a goniometer (instrument that measures an angle of a joint) to measure the degree of knee flexion and extension of a patient. Knee ROM of both the operated and injected knees will be taken. Knee Flexion - the measurable degree in which the leg (and knee joint) is bent. Knee Extension - The measurable degree in which the knee is extended (making the joint angle larger, or straightening the knee.

Time frame
4-, 8-, 12-weeks and 1-year post-surgery
4

Timed Up Go Test (TUG)

TUG is a simple test used to assess a person's mobility (in seconds) and requires both static and dynamic balance. A line is placed on the floor 3 meters away from a chair where patient will be sitting. When instructed to "GO" patient will stand, walk to a line on the floor at his/her regular pace, turn around and walk back to the chair and sit down. The longer it takes for subject to complete the test, higher is the risk of fall and lower is the its functional mobility. Reference values are: 60-69 years old = 8.1 seconds; 70-79 years old = 9.2 seconds; 80-99 years old = 11.3 seconds. Over 14 seconds is associate with high risk of fall

Time frame
4-, 8-, 12-weeks and 1-year post-surgery

Other outcomes

1

Feasibility - recruitment

Ability to recruit 60 patients.

Time frame
2 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.